The Department of Health and Human Services (HHS) gave over $600,000 to Rutgers for a study on the effects of “anti-disinformation” messages about menthol cigarettes in the African-American community starting in July, according to a government website.
The Food and Drug Administration (FDA) proposed banning menthol cigarettes and flavored cigars in April 2022 to increase “health equity,” and soon after, the tobacco industry “promulgated disinformation in African American communities,” according to the grant’s abstract. The study proposes to use a four-step process to study how “anti-disinformation messages” affect African American’s views of the proposed FDA ban.
“The tobacco industry and its sources promulgated disinformation in African American communities about the increased criminalization and police discrimination for using tobacco products when the rules are enforced,” the study’s abstract reads.
The study will take a four-step approach, including “community-based participatory research methods,” characterizing the tobacco industry rhetoric, and tracking participants’ feelings about the ban, according to the grant. It will then use the information learned about participants’ feelings to conduct randomized testing and evaluate the effectiveness of the “anti-disinformation” campaign.
“African Americans have high rates of menthol cigarette and flavored cigar use, which likely contributes to their disproportionate experience of tobacco-related health conditions,” the study’s abstract reads.
Over 18 million Americans smoke menthol cigarettes, and a ban would reduce tobacco-related deaths in the country, according to the FDA. Between 1980 and 2018, 40% of excess deaths from menthol cigarette smoking were African Americans.
The FDA sent a final draft of the menthol cigarette ban to the White House on Oct 13. The information learned in the study will help guide the FDA’s Center for Tobacco Products Communication Office and local public health departments’ approaches to communicating about the proposed ban to African Americans, according to the grant. The grant’s funding started July 19, 2023, and is slated to end Jan. 31, 2028.
The FDA did not immediately respond to the Daily Caller News Foundation’s request for comment.
All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- University ‘forces’ journalism students to fork over tuition money for course on ‘microaggressions,’ pronouns - March 18, 2024
- ‘They’re distracting’: Schools lock up phones as kids struggle to pay attention in class - March 15, 2024
- Blue city teachers’ union yanking kids from class to attend get out the vote event for cause it supports - March 15, 2024
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
